Louisiana 2022 Regular Session

Louisiana Senate Bill SB32 Latest Draft

Bill / Engrossed Version

                            SLS 22RS-23	ENGROSSED
2022 Regular Session
SENATE BILL NO. 32
BY SENATORS FRED MILLS AND CLOUD 
PHARMACISTS.  Provides relative to pharmacy audits. (8/1/22)
1	AN ACT
2 To amend and reenact R.S. 22:1856(B) and 1856.1(A), the introductory paragraph of
3 1856.1(B), 1856.1(B)(2)(a), (3)(a), and (4)(a), (E)(5), and (G), and to enact R.S.
4 22:1856.1(H) and 1856.2, relative to pharmacy audits; to provide for the time limit
5 for pharmacy audits; to provide for the prescriptions audited; to provide for
6 compensation of auditors; to require an attestation prior to an audit; and to provide
7 for related matters.
8 Be it enacted by the Legislature of Louisiana:
9 Section 1.  R.S. 22:1856(B) and 1856.1(A), the introductory paragraph of 1856.1(B),
10 1856.1(B)(2)(a), (3)(a), and (4)(a), (E)(5), and (G) are hereby amended and reenacted and
11 R.S. 22:1856.1(H) and 1856.2 are hereby enacted to read as follows:
12 §1856. Payment standard; limitations on claim filing and audits; remittance advice
13	*          *          *
14	B. Health insurance issuers that limit the period of time that a pharmacist or
15 pharmacy under contract for delivery of covered benefits has to submit claims for
16 payment under R.S. 22:1853 or 1854 shall have the same limited period of time
17 following payment of such claims to perform any review or audit for purposes of
Page 1 of 5
Coding: Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions. SB NO. 32
SLS 22RS-23	ENGROSSED
1 reconsidering the validity of such claims.
2	A pharmacy record audit, reconsideration, or any other review of a
3 claim for delivery of covered benefits performed by a health insurance issuer
4 or their representative shall be done in accordance with R.S. 22:1856.1.
5	*          *          *
6 §1856.1. Pharmacy record audits; recoupment; appeals
7	A.(1)  As used in this Section, "entity" means a managed care company,
8 insurance company, third-party payor, or the representative of the managed care
9 company including a pharmacy benefit manager, insurance company, or third-party
10 payor.
11	(2) Except for an alleged fraud, willful misrepresentation, or abuse audit
12 performed in accordance with Paragraph (G)(2) of this Section, any entity that
13 limits the period of time that a pharmacist or pharmacy under contract for
14 delivery of covered benefits has to submit claims for payment pursuant to R.S.
15 22:1853 or 1854 shall have the same limited period of time following payment
16 of the claims, up to a maximum time period of one year from the date the claim
17 was adjudicated, to perform an audit, reconsideration, or any other review of
18 a claim.
19	B. Notwithstanding any other provision of law to the contrary, when an a
20 review, reconsideration, or any other audit of the records of a pharmacy is
21 conducted by an entity, the audit shall be conducted in accordance with the following
22 criteria:
23	*          *          *
24	(2)(a) No entity shall conduct an audit at a particular pharmacy more than one
25 time or for more than one hundred prescriptions annually. However, the
26 provisions of this Paragraph shall not apply when an entity must return to a
27 pharmacy to complete an audit already in progress, or there is an identified history
28 of errors, an identified activity which a reasonable man would believe to be
29 inappropriate, or illegal activity that the entity has brought to the attention of the
Page 2 of 5
Coding: Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions. SB NO. 32
SLS 22RS-23	ENGROSSED
1 pharmacy owner or corporate headquarters of the pharmacy.
2	*          *          *
3	(3)(a) The entity or any vendor or subcontractor of the entity which conducts
4 the initial audit shall give the pharmacy notice and a comprehensive list of claims
5 by prescription number to be audited at least two weeks before conducting the
6 initial audit for each audit cycle. The entity or vendor or subcontractor of the
7 entity shall not receive payment nor compensate the auditor based on the
8 amount directly or indirectly recovered.
9	*          *          *
10	(4)(a)(i) Any clerical or record-keeping error, such as a typographical error,
11 scrivener's error, or computer error, regarding a required document or record shall
12 not necessarily constitute fraud.
13	(ii) A claim arising pursuant to the provisions of this Section may be subject
14 to recoupment.
15	*          *          *
16	E.	*          *          *
17	(5) Notwithstanding any other provision of law to the contrary, the agency
18 entity conducting the audit shall not use the accounting practice of extrapolation in
19 calculating recoupment or penalties for audits, unless otherwise agreed to by the
20 pharmacy or mandated by a government agency or in the case of fraud.
21	*          *          *
22	G. This Section shall not apply to:
23	(1) Any quality assurance review, as defined by the time period prior to the
24 reimbursement by the entity to the pharmacy dispensing of the prescription.
25	(2) An investigation that is initiated based on or that involves suspected or
26 alleged fraud, willful misrepresentation, or abuse. The entity conducting the audit
27 shall provide notice of any investigation initiated pursuant to this Subsection to
28 the division of insurance fraud of the Department of Insurance prior to auditing
29 the pharmacy.
Page 3 of 5
Coding: Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions. SB NO. 32
SLS 22RS-23	ENGROSSED
1	H. If, upon investigation, the commissioner of insurance finds a violation
2 of this Section has occurred, either on his own initiative or in response to a
3 complaint filed with the Department of Insurance, the commissioner shall
4 suspend or revoke the license of the entity or, in lieu thereof, impose a fine.
5 §1856.2.  Pharmacy record auditors; attestation required
6	A.  On or after January 1, 2023, no individual shall perform an audit on
7 behalf of an entity pursuant to R.S. 22:1856.1 or any other provision of this
8 Subpart unless the individual has attested in writing to the entity on whose
9 behalf he is performing the audit that the individual is knowledgeable of
10 Louisiana pharmacy audit laws and his intent to conduct the audit in
11 compliance with Louisiana law.
12	B. An entity's failure to maintain a copy of the attestation required by
13 this Subpart constitutes a violation of R.S. 22:1964(16).
14	C. Any audit conducted by any individual who has not attested in writing
15 as required by this Subpart is invalid and of no effect between the parties.
The original instrument and the following digest, which constitutes no part
of the legislative instrument, were prepared by Brandi Cannon.
DIGEST
SB 32 Engrossed 2022 Regular Session	Fred Mills
Present law provides for the payment for prescription drugs, other products and supplies, and
pharmacist services submitted by a pharmacist or pharmacy under a contract for the
provision of covered benefits with a health insurance issuer.
Present law provides that health insurance issuers that limit the period of time that a
pharmacist or pharmacy has to submit claims for payment shall have the same limited period
of time following payment of the claims to reconsider the validity of the claims. Proposed
law provides that, except in cases of alleged fraud, willful misrepresentation, or abuse, the
time period shall not exceed one year from the date a claim was adjudicated to perform any
review, reconsideration, or any other audit of the claim.
Present law provides for the audit of pharmacy records and prohibits the conducting of an
audit at a particular pharmacy more than one time annually. Proposed law also prohibits an
audit for more than 100 prescriptions annually.
Present law provides that the entity which conducts the initial audit shall give the pharmacy
notice at least two weeks before conducting the initial audit except in cases of alleged fraud
or willful misrepresentation when notice before the initial audit could impede the audit,
review, or investigation. Proposed law adds the requirement for the auditor to provide a
comprehensive list of claims by prescription number to be audited.
Page 4 of 5
Coding: Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions. SB NO. 32
SLS 22RS-23	ENGROSSED
Proposed law provides that the auditor shall not receive payment nor be compensated based
on the amount directly or indirectly recovered.
Proposed law provides that the auditor shall provide notice of any investigation initiated
based upon fraud to the division of insurance fraud of the Department of Insurance prior to
auditing the pharmacy. Proposed law requires the commissioner of insurance to take
appropriate enforcement action.
Proposed law provides that, effective January 1, 2023, no individual shall perform an audit
unless the individual has attested in writing to the entity on whose behalf he is performing
the audit that the individual is knowledgeable of Louisiana pharmacy audit laws and his
intent to conduct the audit in compliance with Louisiana law.
Effective August 1, 2022.
(Amends R.S. 22:1856(B) and 1856.1(A), 1856.1(B)(intro para), (B)(2)(a), (3)(a), and (4)(a),
(E)(5), and (G); adds R.S. 22:1856.1(H) and 1856.2)
Page 5 of 5
Coding: Words which are struck through are deletions from existing law;
words in boldface type and underscored are additions.